SALITURO FRANCESCO G.,ANN DAK-YEE KWONG,COURT JOHN J.,LIN CHAO,GU WENXIN,JIANG MIN,WANNAMAKER M. WOODS,BETHIEL RANDY S.,PEROLA EMANUELE,KENNEDY JOSEPH M.,BYRN RANDAL,MALTAIS FRANCOIS,DENG HONGBO,DUFFY
申请号：
NZ61925910
公开号：
NZ619259A
申请日:
2010.06.17
申请国别(地区):
NZ
年份:
2015
代理人:
摘要：
Disclosed herein are methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (IA): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.
